Cargando…
Oral Vaccination with Engineered Probiotic Limosilactobacillus reuteri Has Protective Effects against Localized and Systemic Staphylococcus aureus Infection
Staphylococcus aureus is a Gram-positive bacterium responsible for most hospital-acquired (nosocomial) and community-acquired infections worldwide. The only therapeutic strategy against S. aureus-induced infections, to date, is antibiotic treatment. A protective vaccine is urgently needed in view of...
Autores principales: | Pan, Na, Liu, Yang, Zhang, Haochi, Xu, Ying, Bao, Xuemei, Sheng, Shouxin, Liang, Yanchen, Liu, Bohui, Lyu, Yueqing, Li, Haotian, Ma, Fangfei, Pan, Haiting, Wang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100842/ https://www.ncbi.nlm.nih.gov/pubmed/36723073 http://dx.doi.org/10.1128/spectrum.03673-22 |
Ejemplares similares
-
Oral Delivery of Novel Recombinant Lactobacillus Elicit High Protection against Staphylococcus aureus Pulmonary and Skin Infections
por: Pan, Na, et al.
Publicado: (2021) -
Vaccine Composition Formulated with a Novel Lactobacillus-Derived Exopolysaccharides Adjuvant Provided High Protection against Staphylococcus aureus
por: Zhang, Haochi, et al.
Publicado: (2021) -
Oral Administration with Recombinant Attenuated Regulated Delayed Lysis Salmonella Vaccines Protecting against Staphylococcus aureus Kidney Abscess Formation
por: Liang, Yanchen, et al.
Publicado: (2022) -
Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
por: Piccioni, Andrea, et al.
Publicado: (2021) -
Mammary γδ T cells promote IL-17A-mediated immunity against Staphylococcus aureus-induced mastitis in a microbiota-dependent manner
por: Pan, Na, et al.
Publicado: (2023)